Replies to post #199941 on Cytodyn Inc (CYDY)

[theswordman]

This is NOT some "excellent summary"--it is FALSE
just 1 example or 5!!!
______________________________________________________
"Revenue recognized was approximately $225.0 thousand and $266.0 thousand for the three and six months ended November 30, 2021, respectively..." (est $491K)--IT IS NOT CUMULATIVE--It is 225K for 3 months and 266K or the 6 months (est $266K)--NOT 491K
_______________________________________________________
"Naders proactive video was really him being proactive. He said we had about $8M "--he said as of 30 NOV!!!
_______________________________________________________
"Personal belief: I feel we are raising money as little as possible. We only want to have about $6-10M on hand."--We are NOT PAYING BILLS --see Samsung and amarex. See trial enrollment in Brazil
_______________________________________________________
"Bottom line is, the FDA said our drug is slightly better than an approved drug in Oncology"--NOT TRUE--nodder said that--NOT THE FDA
_____________________________________________________
"And now we may have in question of a $6.5M bond, something that could be delayed for several months if the company doesn’t have it."--How can the company NOT HAVE IT?? You just stated they have 200 million shares to sell?? ANY delay in amarex bond is delay in BLA. GET READY

[kevindenver]

"The last proactive video, NP said he would go Fund Raise."

I'm sure he will try as there are firms lower thanFife and Paulson that will do small toxic deals. However, I bet warrants won't be an option anymore. The toxic terms of equity financing will be at a direct discount to the market price.

[3X Charm]

Actually, pretty ridiculous summary full of “hopefully and want to be’s”, but no reality. More speculation and no meat.

Over the weekend, I outlined why when the stock hit $.70 this year , it is much different than 2019.
The dire 10 Q validates the truth about Cydy that was clear to any balanced observer… Cydy has become a dumpster fire run by greedy and incompetent executives.

There is little hope as 200 m shares in the $.50 range will be lucky to fetch $75 million in the large raise required…And who’s going to buy with the horrible news in this 10q or partner with NP?

With SEC and DOJ investigations, along with poor relationships with FDA, Nader and Kelly are anchors weighing this company down and always have been.